Scientific Precision Meets AI Innovation

Innovation at the
Intersection of Drug
Development and Data Science

Innovation at the
Intersection of Drug
Development and Data Science

Innovation at the
Intersection of Drug
Development and Data Science

  • Extended timelines for drug approval of 10-15 years.

  • An ever-increasing average price tag to develop a drug, now at $2.6B.

  • Low approval ratings, with only 12% of new molecular entities that enter clinical trials receiving FDA approval.

  • Extended timelines for drug approval of 10-15 years.

  • An ever-increasing average price tag to develop a drug, now at $2.6B.

  • Low approval ratings, with only 12% of new molecular entities that enter clinical trials receiving FDA approval.

  • Extended timelines for drug approval of 10-15 years.

  • An ever-increasing average price tag to develop a drug, now at $2.6B.

  • Low approval ratings, with only 12% of new molecular entities that enter clinical trials receiving FDA approval.

De-Risk High Stakes Decisions

DeRisk-high-stakes-decisions

De-Risk High Stakes Decisions

De-Risk High Stakes Decisions
Clinical Development Insights

Clinical Development Insights [Beta]

Clinical Development
Insights [Beta]

Clinical Development Insights

Data & Insights

Data & Insights

Who We Work With

Who We Work With